|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
�������չ��� |
|
���� |
| ��������������� | |
|
��ͮ�� |
|
���� |
| PubMed | |
|
Article by |
|
Article by |
�������չ���ķ������ƺ����ƽ�չ
��ͮ��, ����
����ҽѧԺ��һ����ҽԺƤ����, 650032
�������չ�����һ�ֳ��������ԡ��ط��ԡ����չ������йصĹ�����Ƥ����,�䲡����������δ����.�������Ŵ������ߡ��������ڷ��ڼ���л�����������й�.Ŀǰ��Ϊ,Ԥ�������Ƹ���Ҫ,���Ƽ��⻯ѧ�Ʒ��������ضȲ����нϺ���Ч,Ƥ����̴�����űҩ��ϵͳ������Ч�����Ʒ�����Ȼ�д���һ��̽��.
[2] Epstein JH. Polymorphous light eruption. Photodermatol Photoimmunol Photomed, 1997, 13(3):89-90.
[3] Stratigos AJ, Antoniou C, Katsambas AD. Polymorphous light eruption. J Eur Acad Dermatol Venereol, 2002, 16(3):193-206.
[4] Mastalier U, Kerl H, Wolf P. Clinical, laboratory, phototest and phototherapy findings in polymorphic light eruptions:a retrospective study of 133 patients. Eur J Dermatol, 1998, 8(8):554-559.
[5] McGregor JM, Grabczynska S, Vaughan R, et al. Genetic modeling of abnormal photosensitivity in families with polymorphic light eruption and actinic prurigo. J Invest Dermatol, 2000, 115(3):471-476.
[6] Leroy D, Dompmartin A, Verneuil L, et al. Polychromatic phototest sensibility is superior to UVA phototest in polymorphic light eruptions,Ann Dermatol Venereol, 2002, 129(6-7):860-864.
[7] Hasan T, Ranki.A, Jansen CT, et al. Disease associations in polymorphous light eruption. A long-term follow-up study of 94 patients.Arch Dermatol, 1998, 134(9):1081-1085.
[8] Norris P, Bacon K, Bird C, et al. The role of interleukins 1,6 and 8as lymphocyte attractants in the photodermatoses polymorphic light eruption and chronic actinic dermatitis. Clin Exp Dermatol, 1999, 24(4):321-326.
[9] Kolgen W, Van Weelden H, Den Hengst S, et al. CD11b+ cells and ultraviolet-B-resistant CD1 a+ cells in skin of patients with polymorphous light eruption. J Invest Dermatol, 1999, 113(1):4-10.
[10] Grabczynska SA, McGregor JM, Kondeatis E, et al. Actinic prurigo and polymorphic light eruption:common pathogenesis and the importance of HLA-DR4/DRB1* 0407. Br J Dermatol, 1999, 140(2):232-236.
[11] Bataille V, MacGregor A, McGregor JM, et al. The heritability of Photosensitivity in monozygous and dizygous twins. Br J Dermatol,1998, 138(4):734.
[12] Millard TP, Bataille V, Snieder H,et al. The heritability of polymorphic light eruption. J Invest Dermatol, 2000, 115(3):467-470.
[13] Craig PS, Diffey BL. A prospective longitudinal study of the outdoor behaviour and symptoms of photosensitive patients. Br J Dermatol,1997, 137(3):391-394.
[14] Eberlein-Konig B, Fesq H, Abeck D, et al. Systemic vitamin C and vitamin E do not prevent photoprovocation test reactions in polymorphous light eruption. Photodermatol Photoimmunol Photomed, 2000,16(2):50-52.
[15] Rippke F, Wendt G, Bohnsack K, et al. Results of photoprovocation and field studies on the efficacy of a novel topically applied antioxidant in polymorphous light eruption. J Dermatolog Treat, 2001, 12(1):3-8.
[16] Millard TP, Hawk JL. Photosensitivity disorders:cause, effect and management. Am J Clin Dermatol, 2002, 3(4):239-246.
[17] Cayrol C, Sarraute J, Tarroux R, et al. A mineral sunscreen affords genomic protection against.ultraviolet(UV)B and UVA radiation:in vitro and in situ assays. Br J Dermatol, 1999, 141(2):250-258.
[18] Diffey BL. When should sunscreen be reapplied? J Am Acad Dermatol, 2001,45(6):882-885.
[19] Ledo E, Ledo A. Phototherapy, photochemotherapy, and photodynamic therapy:unapproved uses or indications. Clin Dermatol, 2000,18(1):77-86.
[20] Patel DC, Bellaney GJ, Seed PT, et al. Efficacy of short-course oral prednisolone in polymorphic light eruption:a randomized controlled trial. Br J Dermatol, 2000, 143(4):828-831.
[21] Wolf R, Wolf D, Ruocco V. Antimalarials:unapproved uses or indications. Clin Dermatol, 2000, 18(1):17-35.
[22] No authors listed. Hydroxychloroquine in light eruption:new indication. Can be tried. Prescrire Int, 1999, 8(41):72-73.
[23] Shipley DR, Hewitt JB. Polymorphic light eruption treated with cyclosporin. Br J Dermatol, 2001, 144(2):446-447.
[24] Hadshiew I, Stab F, Untiedt S, et al. Effects of topically applied antioxidants in experimentally provoked polymorphous light eruption.Dermatology, 1997, 195(4):362-368.
[25] Creamer D, McGregor JM, Hawk JL. Polymorphic light eruption occurring in common variable hypogammaglobulinaemia, and resolving with intravenous immunoglobulin therapy. Clin Exp Dermatol, 1999,24(4):273-274.